Kiviaho Jenny K, Anttonen Mikko, Alfthan Henrik, Itkonen Outi
Department of Clinical Chemistry, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, P.O. Box 720, HUS, FI-00029, Finland.
Department of Clinical Chemistry, HUS Diagnostic Centre, Helsinki University Hospital and University of Helsinki, P.O. Box 720, HUS, FI-00029, Finland.
Clin Chim Acta. 2026 Jan 1;578:120541. doi: 10.1016/j.cca.2025.120541. Epub 2025 Aug 7.
Quantitation of fecal elastase 1 (FE-1) is a non-invasive test for pancreatic function to detect moderate or severe exocrine insufficiency. The enzyme-linked immunosorbent assays (ELISA) are well-established tests for FE-1 detection. Traditional sample preparation by manual weighing and extraction is laborious, but new sample devices allow more effective sample preparation. FE-1 in stool has good stability but systematic studies on FE-1 stability in sampling and extraction devices are lacking. We examined the stability of FE-1 in the IDK Extract® device and intact stool samples at room temperature, 4 °C or -20 °C. Furthermore, we assessed the suitability of the IDK Extract® device for FE-1 testing and compared the performance of IDK FE-1 ELISA to that of the established ScheBo assay. FE-1 is stable in IDK Extract® device and intact stool for at least 29 days at all storage temperatures tested with deviation < 20 % from day zero concentration. When compared to weighing, the IDK Extract® device proved to be a reliable tool for sample preparation. Based on common clinical decision limits of pancreatic exocrine function, the ScheBo and IDK assays showed good agreement. In conclusion, IDK FE-1 assay together with the IDK Extract® device offers an effective and reliable method to determine exocrine pancreatic insufficiency. FE-1 is stable at various temperatures and the IDK and ScheBo assays perform equally. Thus, stool samples from outpatient clinics can be transported to the analytical laboratory cost-effectively at room temperature.
粪便弹性蛋白酶1(FE-1)定量检测是一种用于检测胰腺功能以发现中度或重度外分泌功能不全的非侵入性检测方法。酶联免疫吸附测定(ELISA)是检测FE-1的成熟检测方法。传统的通过手工称重和提取进行样本制备的方法很费力,但新型样本装置能实现更有效的样本制备。粪便中的FE-1具有良好的稳定性,但缺乏关于FE-1在采样和提取装置中稳定性的系统性研究。我们检测了FE-1在IDK Extract®装置和完整粪便样本中在室温、4℃或-20℃下的稳定性。此外,我们评估了IDK Extract®装置用于FE-1检测的适用性,并将IDK FE-1 ELISA的性能与既定的ScheBo检测法进行了比较。在所有测试的储存温度下,FE-1在IDK Extract®装置和完整粪便中至少29天稳定,与零日浓度的偏差<20%。与称重法相比,IDK Extract®装置被证明是一种可靠的样本制备工具。基于胰腺外分泌功能的常见临床决策界限,ScheBo检测法和IDK检测法显示出良好的一致性。总之,IDK FE-1检测法与IDK Extract®装置一起提供了一种有效且可靠的方法来确定胰腺外分泌功能不全。FE-1在各种温度下都稳定,IDK检测法和ScheBo检测法表现相当。因此,门诊诊所的粪便样本可以在室温下经济高效地运送到分析实验室。